Learn More/Clinical Trials & Research
Research

Clinical Trials & Research for Erectile Dysfunction

Explore current clinical trials, research studies, and breakthrough treatments for erectile dysfunction. Learn how to participate in advancing ED care.

Why ED Research Matters

Clinical research is essential for developing new and better treatments for erectile dysfunction. Through rigorous scientific studies, researchers work to understand the causes of ED and test innovative therapies that could help millions of men worldwide.

200+

Active ED studies worldwide

15-20

Years average drug development

$2.6B

Average cost to develop new drug

Current Research Areas

Novel Medications

New Drug Classes:

  • Melanocortin receptor agonists: Target brain pathways
  • Rho-kinase inhibitors: Improve smooth muscle relaxation
  • Soluble guanylate cyclase activators: Enhance nitric oxide pathway
  • Topical formulations: Direct penile application

Improved Delivery:

  • Sublingual tablets: Faster absorption
  • Nasal sprays: Rapid onset
  • Transdermal patches: Sustained release
  • Intraurethral suppositories: Local delivery

Regenerative Medicine

Stem Cell Therapy

Using stem cells to regenerate damaged penile tissue and blood vessels.

Platelet-Rich Plasma

Injecting concentrated platelets to promote tissue healing and growth.

Gene Therapy

Delivering genes to enhance nitric oxide production or blood vessel growth.

Medical Devices

Advanced Technologies:

  • Low-intensity shock wave therapy: Improved protocols
  • Electromagnetic field therapy: Non-invasive stimulation
  • Robotic penile implants: Smart, adjustable devices
  • Tissue engineering: Bioengineered penile tissue

Diagnostic Tools:

  • Advanced imaging: Better visualization techniques
  • Biomarker testing: Blood tests for ED prediction
  • Wearable monitors: Continuous erectile function tracking
  • AI-powered analysis: Improved diagnosis accuracy

Types of Clinical Trials

Phase I Trials

First human testing of new treatments to evaluate safety and determine dosage.

  • • Small number of participants (20-100)
  • • Focus on safety and side effects
  • • Determine optimal dosing
  • • Duration: Several months

Phase II Trials

Test effectiveness while continuing to monitor safety in larger groups.

  • • Moderate number of participants (100-300)
  • • Evaluate treatment effectiveness
  • • Continue safety monitoring
  • • Duration: Several months to 2 years

Phase III Trials

Large-scale studies comparing new treatment to current standard of care.

  • • Large number of participants (300-3000)
  • • Compare to existing treatments
  • • Multiple study locations
  • • Duration: 1-4 years

Phase IV Trials

Post-market surveillance to monitor long-term effects of approved treatments.

  • • Very large populations (thousands)
  • • Long-term safety monitoring
  • • Real-world effectiveness
  • • Duration: Years to decades

Participating in Clinical Trials

Benefits of Participation

  • Access to cutting-edge treatments: Try new therapies before they're widely available
  • Expert medical care: Close monitoring by specialized research teams
  • Contribute to science: Help advance treatment for future patients
  • No cost treatment: Study medications and procedures provided free
  • Comprehensive evaluation: Detailed health assessments

Potential Risks

  • Unknown side effects: New treatments may have unexpected reactions
  • Treatment may not work: Experimental therapies might be ineffective
  • Time commitment: Regular visits and monitoring required
  • Placebo possibility: May receive inactive treatment in some studies
  • Lifestyle restrictions: Study protocols may limit activities

Eligibility and Enrollment Process

Common Eligibility Criteria

Inclusion Criteria:

  • • Diagnosed with ED for specific duration
  • • Age range (typically 18-75 years)
  • • Stable relationship (for some studies)
  • • Specific ED severity level
  • • Ability to provide informed consent

Exclusion Criteria:

  • • Certain medical conditions
  • • Current use of specific medications
  • • Recent heart attack or stroke
  • • Substance abuse history
  • • Participation in other studies

Enrollment Process

  1. 1. Initial screening: Phone or online questionnaire
  2. 2. Informed consent: Detailed explanation of study risks and benefits
  3. 3. Medical evaluation: Physical exam, lab tests, medical history
  4. 4. Eligibility confirmation: Final determination of study participation
  5. 5. Randomization: Assignment to treatment or control group
  6. 6. Baseline assessments: Pre-treatment measurements and evaluations

Finding Clinical Trials

Online Resources

  • ClinicalTrials.gov: Official U.S. database of clinical studies
  • WHO Clinical Trials Registry: International trial database
  • University medical centers: Academic research institutions
  • Pharmaceutical companies: Industry-sponsored studies
  • Patient advocacy groups: ED-specific organizations

Healthcare Providers

  • Urologists: Specialists in male sexual health
  • Research coordinators: Clinical trial specialists
  • Primary care doctors: May know of local studies
  • ED clinics: Specialized treatment centers
  • Academic medical centers: University hospitals

Recent Research Breakthroughs

Low-Intensity Shock Wave Therapy

Studies show promising results for improving erectile function through non-invasive shock wave treatment.

Results: 60-70% of men show improvement in erectile function scores

Platelet-Rich Plasma (PRP) Therapy

Early studies suggest PRP injections may help regenerate penile tissue and improve function.

Status: Phase II trials ongoing, preliminary results encouraging

Topical Alprostadil Cream

New formulations of topical ED medications showing improved absorption and effectiveness.

Advantage: Non-invasive alternative to injections with fewer side effects

Patient Rights and Safety

Your Rights as a Research Participant

  • Informed consent: Full disclosure of risks and benefits
  • Voluntary participation: No pressure to join or continue
  • Right to withdraw: Leave the study at any time
  • Privacy protection: Confidential handling of medical information
  • Safety monitoring: Regular health assessments
  • Access to results: Information about study outcomes
  • Compensation: Reimbursement for time and travel
  • Emergency care: Treatment for study-related injuries

Get Involved in ED Research

Clinical research participation is a valuable way to access cutting-edge treatments while contributing to the advancement of ED care for future generations.

Ask ED